Non-Dissecting Distal Aortic and Peripheral Arterial Aneurysms in Patients With Marfan Syndrome.

Marfan syndrome aortic aneurysm aortic dissection peripheral aneurysms vascular surgery

Journal

Frontiers in cardiovascular medicine
ISSN: 2297-055X
Titre abrégé: Front Cardiovasc Med
Pays: Switzerland
ID NLM: 101653388

Informations de publication

Date de publication:
2022
Historique:
received: 01 12 2021
accepted: 28 01 2022
entrez: 1 4 2022
pubmed: 2 4 2022
medline: 2 4 2022
Statut: epublish

Résumé

In Marfan syndrome (MFS), an aortic or peripheral arterial dilatation is usually the consequence of aortic dissection. Non-dissecting distal aortic and peripheral aneurysms (DAPA) are barely described. We sought to determine the incidence and prognostic impact of non-dissecting DAPA, requiring a surgical repair in a large population of patients with MFS. The patients referred to the French MFS reference center were included in a prospective database, and the patients treated for a non-dissecting DAPA between 2013 and 2020 were retrospectively reviewed. The first-line therapy was open surgery. The patients unfit for open repair or experiencing life-threatening complications underwent endovascular repair. Among 1,575 patients with MFS, 19 (1.2%) were operated for 25 non-dissecting DAPA. The mean age was 42.4 ± 11.5 years. Non-dissecting DAPA involved the subclavian or axillary artery ( Among the patients with MFS, the diagnosis of non-dissecting DAPA is infrequent but is associated with a significant adverse outcome, thus, advocating for a specific follow-up.

Sections du résumé

Background UNASSIGNED
In Marfan syndrome (MFS), an aortic or peripheral arterial dilatation is usually the consequence of aortic dissection. Non-dissecting distal aortic and peripheral aneurysms (DAPA) are barely described. We sought to determine the incidence and prognostic impact of non-dissecting DAPA, requiring a surgical repair in a large population of patients with MFS.
Methods UNASSIGNED
The patients referred to the French MFS reference center were included in a prospective database, and the patients treated for a non-dissecting DAPA between 2013 and 2020 were retrospectively reviewed. The first-line therapy was open surgery. The patients unfit for open repair or experiencing life-threatening complications underwent endovascular repair.
Results UNASSIGNED
Among 1,575 patients with MFS, 19 (1.2%) were operated for 25 non-dissecting DAPA. The mean age was 42.4 ± 11.5 years. Non-dissecting DAPA involved the subclavian or axillary artery (
Conclusion UNASSIGNED
Among the patients with MFS, the diagnosis of non-dissecting DAPA is infrequent but is associated with a significant adverse outcome, thus, advocating for a specific follow-up.

Identifiants

pubmed: 35360038
doi: 10.3389/fcvm.2022.827357
pmc: PMC8962944
doi:

Types de publication

Journal Article

Langues

eng

Pagination

827357

Informations de copyright

Copyright © 2022 Pellenc, Boitet, Roussel, Milleron, Mordant, Senemaud, Cerceau, Jondeau and Castier.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Circulation. 2008 May 27;117(21):2802-13
pubmed: 18506019
Int J Cardiol. 2014;172(1):e94-5
pubmed: 24433614
J Thorac Cardiovasc Surg. 2018 Nov;156(5):1787-1793
pubmed: 29934004
J Med Genet. 2010 Jul;47(7):476-85
pubmed: 20591885
Genet Med. 2021 Jul;23(7):1296-1304
pubmed: 33731877
J Am Coll Cardiol. 2021 Jun 22;77(24):3005-3012
pubmed: 34140103
Eur Heart J. 2021 Feb 11;42(6):563-645
pubmed: 32860028
J Am Coll Cardiol. 2021 Jun 22;77(24):3013-3015
pubmed: 34140104
J Am Coll Cardiol. 2011 Dec 6;58(24):2544-5
pubmed: 22133857
J Vasc Surg. 2009 Nov;50(5):987-91
pubmed: 19632806
Eur J Vasc Endovasc Surg. 2017 Jan;53(1):4-52
pubmed: 28081802
J Vasc Surg. 2020 Nov;72(5):1761-1769
pubmed: 32482544
N Engl J Med. 2006 Aug 24;355(8):788-98
pubmed: 16928994
Eur J Vasc Endovasc Surg. 2020 Apr;59(4):577-585
pubmed: 31865029
Br J Surg. 1981 Apr;68(4):267-72
pubmed: 7225742
Ann Thorac Surg. 2005 Mar;79(3):796-800
pubmed: 15734380
Nat Rev Dis Primers. 2021 Sep 2;7(1):64
pubmed: 34475413
J Vasc Surg. 2018 Aug;68(2):364-371
pubmed: 29567025
J Vasc Surg. 2012 May;55(5):1234-40; disucssion 1240-1
pubmed: 22465552
Catheter Cardiovasc Interv. 2013 Dec 1;82(7):E898-905
pubmed: 23576534
JACC Cardiovasc Interv. 2008 Dec;1(6):673-80
pubmed: 19463383
J Thorac Cardiovasc Surg. 2009 Nov;138(5):1108-14
pubmed: 19660372
J Endovasc Ther. 2008 Apr;15(2):144-9
pubmed: 18426270
Eur Heart J. 2014 Nov 1;35(41):2873-926
pubmed: 25173340
Circulation. 2020 May 12;141(19):1570-1587
pubmed: 32392100
J Endovasc Ther. 2005 Feb;12(1):82-8
pubmed: 15683276

Auteurs

Quentin Pellenc (Q)

Department of Vascular and Thoracic Surgery, Bichat Hospital, Assistance Publique-Hopitaux de Paris (AP-HP), Paris, France.
Centre de Référence pour le Syndrome de Marfan et apparentés, Bichat Hospital, Assistance Publique-Hopitaux de Paris (AP-HP), Paris, France.
INSERM U 1148, LVTS, Bichat Hospital, Paris, France.
Université de Paris, Paris, France.

Auréline Boitet (A)

Department of Vascular and Thoracic Surgery, Bichat Hospital, Assistance Publique-Hopitaux de Paris (AP-HP), Paris, France.

Arnaud Roussel (A)

Department of Vascular and Thoracic Surgery, Bichat Hospital, Assistance Publique-Hopitaux de Paris (AP-HP), Paris, France.
Université de Paris, Paris, France.

Olivier Milleron (O)

Centre de Référence pour le Syndrome de Marfan et apparentés, Bichat Hospital, Assistance Publique-Hopitaux de Paris (AP-HP), Paris, France.
INSERM U 1148, LVTS, Bichat Hospital, Paris, France.
Department of Cardiology, Bichat Hospital, Assistance Publique-Hopitaux de Paris (AP-HP), Paris, France.

Pierre Mordant (P)

Department of Vascular and Thoracic Surgery, Bichat Hospital, Assistance Publique-Hopitaux de Paris (AP-HP), Paris, France.
Université de Paris, Paris, France.

Jean Senemaud (J)

Department of Vascular and Thoracic Surgery, Bichat Hospital, Assistance Publique-Hopitaux de Paris (AP-HP), Paris, France.
INSERM U 1148, LVTS, Bichat Hospital, Paris, France.
Université de Paris, Paris, France.

Pierre Cerceau (P)

Department of Vascular and Thoracic Surgery, Bichat Hospital, Assistance Publique-Hopitaux de Paris (AP-HP), Paris, France.

Guillaume Jondeau (G)

Centre de Référence pour le Syndrome de Marfan et apparentés, Bichat Hospital, Assistance Publique-Hopitaux de Paris (AP-HP), Paris, France.
INSERM U 1148, LVTS, Bichat Hospital, Paris, France.
Université de Paris, Paris, France.
Department of Cardiology, Bichat Hospital, Assistance Publique-Hopitaux de Paris (AP-HP), Paris, France.

Yves Castier (Y)

Department of Vascular and Thoracic Surgery, Bichat Hospital, Assistance Publique-Hopitaux de Paris (AP-HP), Paris, France.
INSERM U 1148, LVTS, Bichat Hospital, Paris, France.
Université de Paris, Paris, France.

Classifications MeSH